| 摘要 |
<p num="1"><br/><br/><br/>The present invention pertains, at least in part, to novel substituted <br/>tetracycline compounds. <br/>These tetracycline compounds can be used to treat numerous tetracycline <br/>compound-responsive <br/>states, such as bacterial infections and neoplasms, as well as other known <br/>applications for <br/>minocycline and tetracycline compounds in general, such as blocking <br/>tetracycline efflux and <br/>modulation of gene expression.<br/>
|
| 申请人 |
PARATEK PHARMACEUTICALS, INC. |
发明人 |
NELSON, MARK L.;OHEMENG, KWASI;FRECHETTE, ROGER;ABATO, PAUL;BANDARAGE, UPUL;BERNIAC, JOEL;BHATIA, BEENA;CHEN, JACKSON;ISMAIL, MOHAMED Y.;KIM, OAK A.;HONEYMAN, LAURA;PEARSON, ANDRE;REDDY, LAXMA;SHEAHAN, PAUL;VERMA, ATUL K.;VISKI, PETER;WARCHOL, TADEUSZ;AMOO, VICTOR;MECHICHE, RACHID |
